EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Serum pentraxin-3 in patients with chronic obstructive pulmonary disease: A meta-analysis

Yan Zhu, Chongyang Wang

Biomolecules and Biomedicine · 2024

DOI: 10.17305/bb.2024.10875 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Yan Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Shaoxing Seventh People's Hospital, Shaoxing, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Serum Amyloid P-Component, C-Reactive Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The association between serum pentraxin-3 (PTX-3) levels and chronic obstructive pulmonary disease (COPD) has been explored in several studies. However, the results remain inconsistent. This meta-analysis aims to evaluate the differences in serum PTX-3 levels between COPD patients and healthy controls, as well as between patients with acute exacerbations of COPD (AECOPD) and stable COPD. Databases including PubMed, Embase, Web of Science, Wanfang, and China National Knowledge Infrastructure (CNKI) were systematically searched. A random-effects model was used to pool the results, accounting for the potential impact of heterogeneity. Subgroup and meta-regression analyses were performed to evaluate the influence of study characteristics on the outcome. The initial search identified 274 articles, with 17 studies meeting the inclusion criteria. These studies included a total of 996 AECOPD patients, 1414 stable COPD patients, and 1016 healthy controls. The meta-analysis showed significantly higher serum PTX-3 levels in COPD patients compared to healthy controls (standardized mean difference [SMD]: 0.51, 95% confidence interval [CI]: 0.30 to 0.73, P < 0.001; I² = 85%). Subgroup and meta-regression analyses suggested that the results were not significantly affected by the age, sex, or smoking status of the patients. Additionally, serum PTX-3 levels were higher in AECOPD patients compared to stable COPD patients (SMD: 0.58, 95% CI: 0.41 to 0.74, P < 0.001; I² = 59%). In conclusion, serum PTX-3 levels are elevated in COPD patients, particularly during acute exacerbations, compared to stable COPD patients and healthy controls. PTX-3 may serve as a potential biomarker for COPD severity and exacerbation status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveSerum Amyloid P-ComponentC-Reactive ProteinHumansBiomarkersMaleFemalePentraxins

Substanzen

Serum Amyloid P-ComponentC-Reactive ProteinBiomarkersPentraxins

Autor:innen und Institutionen

  • Department of Emergency Medicine, Shaoxing Seventh People's Hospital, Shaoxing, China.

Zitieren

APA

Zhu, Y., & Wang, C. (2024). Serum pentraxin-3 in patients with chronic obstructive pulmonary disease: A meta-analysis. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.10875

Vancouver

Zhu Y, Wang C. Serum pentraxin-3 in patients with chronic obstructive pulmonary disease: A meta-analysis. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.10875

BibTeX
@article{Zhu2024,
  author = {Zhu, Yan and Wang, Chongyang},
  title = {Serum pentraxin-3 in patients with chronic obstructive pulmonary disease: A meta-analysis},
  journal = {Biomolecules and Biomedicine},
  year = {2024},
  doi = {10.17305/bb.2024.10875}
}
Kostenlos starten →